Swiss Re introduces guidance for underwriters on repurposed longevity drugs
Reinsurance News - Aug 12, 2025
Swiss Re’s August 2025 Life Guide has introduced guidance for underwriters on how to assess life insurance applicants who show signs of using repurposed longevity drugs, an emerging trend among health-conscious individuals. The update provides new guidance on medications like metformin and rap...
Recommended Articles
Posted: Apr 16, 2026
Capgemini Research Institute, the research division of the Capgemini, has published the report Physi...
Posted: Apr 16, 2026
Beazley, a large specialist insurer, has announced plans to establish a new Marine War insurance con...
Posted: Apr 16, 2026
John Doyle, President and Chief Executive Officer (CEO) of global insurance and reinsurance broking...